Search

Search Constraints

You searched for: Author/Creator Ueba, Tetsuya

Search Results

3. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma. Issue 3 (30th November 2018)

4. ACTR-01. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP. (11th November 2019)

5. ACTR-62. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP. (5th November 2018)

6. Central nervous system EBV lymphoproliferative disorder in a patient with rhabdomyosarcoma. Issue 5 (6th January 2016)

7. Central nervous system marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue type involving the brain and spinal cord parenchyma. Issue 3 (21st September 2012)

8. CTNI-32. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP. (9th November 2020)